REGENXBIO (NASDAQ:RGNX) Upgraded by StockNews.com to “Hold”
StockNews.com upgraded shares of REGENXBIO (NASDAQ:RGNX – Free Report) from a sell rating to a hold rating in a report issued on Thursday morning. Several other equities research analysts also recently issued reports on RGNX. Robert W. Baird raised their price objective on shares of REGENXBIO from $34.00 to $39.00 and gave the stock an […]
More Stories
Accolade (NASDAQ:ACCD) Posts Quarterly Earnings Results, Beats Expectations By $0.14 EPS
Accolade (NASDAQ:ACCD – Get Free Report) announced its quarterly earnings data on Tuesday. The company reported ($0.30) earnings per share...
News from the WHO: Better use of vaccines could reduce antibiotic use by 2.5 billion doses annually, says WHO https://ift.tt/eG1fTLv October 10, 2024 at 07:00AM
Published on October 10, 2024 at 07:00AM View on website
MIDDLE EAST: Updating live from the Security Council and across the UN
As the crisis in the Middle East grinds on, we are covering the latest updates from the field and at...
Lakeland Financial Co. (NASDAQ:LKFN) to Issue $0.48 Quarterly Dividend
Lakeland Financial Co. (NASDAQ:LKFN – Get Free Report) declared a quarterly dividend on Tuesday, October 8th, Zacks reports. Investors of...
Brinker International (NYSE:EAT) Sets New 52-Week High After Analyst Upgrade
Brinker International, Inc. (NYSE:EAT – Get Free Report)’s share price hit a new 52-week high on Tuesday after Bank of...
Israeli forces fire on UN peacekeepers in Lebanon
Israel Defense Forces (IDF) fired on UN peacekeepers in Lebanon early Thursday morning, according to UNIFIL, the mission operating along...